SCHEMBL13331892

SCHEMBL13331892

CC(C)(C)OC(=O)Nc1cc(C(C)(C)C(=O)O)ccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 1/20 0.44
▸ GSK3B P49841 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ SCN9A Q15858 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ IRAK4 Q9NWZ3 1/20 0.40
▸ NR3C2 P08235 2/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ IGF1R P08069 1/20 0.39
▸ AR P10275 1/20 0.39
▸ PIK3C3 Q8NEB9 1/20 0.39
▸ TGFBR1 P36897 1/20 0.39
▸ CYP17A1 P05093 2/20 0.39
▸ AAK1 Q2M2I8 1/20 0.38
▸ GCK P35557 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TYK2 P29597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12695291 0.84 ALDH1A1 (0.45) ATRGSK3BDYRK1ASCN9AALDH1A1
SCHEMBL13563525 0.84 GAA (0.49) ATRGSK3BDYRK1ASCN9AALDH1A1
SCHEMBL12540480 0.83 ATR (0.42) ATRGSK3BDYRK1ASCN9AALDH1A1
SCHEMBL29272503 0.82 BRAF (0.44) ATRGSK3BDYRK1ASCN9AALDH1A1
SCHEMBL29465812 0.81 KDM4D (0.47) ATRGSK3BDYRK1AALDH1A1IRAK4
SCHEMBL2080457 0.81 KDM4D (0.47) ATRGSK3BDYRK1AALDH1A1IRAK4
SCHEMBL1192656 0.81 ATR (0.50) ATRGSK3BDYRK1ASCN9AGAA
SCHEMBL828560 0.81 TP53 (0.51) ALDH1A1L3MBTL1
SCHEMBL30953487 0.81 ATR (0.50) ATRGSK3BDYRK1ASCN9AGAA
SCHEMBL437390 0.79 ATR (0.52) ATRGSK3BDYRK1AIRAK4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010067131-A1 P38 MAP KINASE INHIBITORS RESPIVERT LIMITED (GB) 2010-06-17 — — WO disclosed
Send feedback